Zhengye Biotechnology Holding Limited Cash and Cash Equivalents
Zhengye Biotechnology Holding Limited (ZYBT) had Cash and Cash Equivalents of CNY 18.60 million as of 2024-12-31, per its 20-F filed 2025-07-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-07-03
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value 18.60M CNY.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value 15.07M CNY.
CNY
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2024-12-31 | 18.60M CNY 20-F · filed 2025-07-03 |
| 2023-12-31 | 15.07M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2024-12-31 | $2.55M 20-F · filed 2025-07-03 |